Estimation of the a / b ratio of non-small cell lung cancer treated with stereotactic body radiotherapy

Please cite this article as: R. J. Klement, J. J. Sonke, M. Allgäuer et al., Estimation of the a/b ratio of non-small cell lung cancer treated with stereotact radiotherapya/b ratio of NSCLC treated with SBRT –>, Radiotherapy and Oncology, https://doi.org/10.1016/j.radonc.2019.07.008 Rainer J. Klement a,⇑, Jan-Jakob Sonke , Michael Allgäuer , Nicolaus Andratschke , Steffen Appold , José Belderbos , Claus Belka , Karin Dieckmann , Hans T. Eich , Michael Flentje , Inga Grills , Michael Eble , Andrew Hope , Anca L. Grosu, Sabine Semrau , Reinhart A. Sweeney , Juliane Hörner-Rieber , Maria Werner-Wasik , Rita Engenhart-Cabillic , Hong Ye , Matthias Guckenberger d

[1]  Shuangbing Xu,et al.  In Vitro Radiobiological Advantages of Hypofractionation Compared with Conventional Fractionation: Early-Passage NSCLC Cells are Less Aggressive after Hypofractionation , 2018, Radiation Research.

[2]  J. Brown,et al.  The Biology of SBRT: LQ or Something New? , 2018, International journal of radiation oncology, biology, physics.

[3]  Jan-Jakob Sonke,et al.  Modeling the Cellular Response of Lung Cancer to Radiation Therapy for a Broad Range of Fractionation Schedules , 2017, Clinical Cancer Research.

[4]  T. Solberg,et al.  Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  Y. Shibamoto,et al.  Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules? , 2016, Journal of radiation research.

[6]  Rita Engenhart-Cabillic,et al.  Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data? , 2016, Radiation Oncology.

[7]  X Allen Li,et al.  An analysis of tumor control probability of stereotactic body radiation therapy for lung cancer with a regrowth model , 2016, Physics in medicine and biology.

[8]  M. Duma,et al.  Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases. , 2016, International Journal of Radiation Oncology, Biology, Physics.

[9]  D. Brenner,et al.  High-dose and fractionation effects in stereotactic radiation therapy: Analysis of tumor control data from 2965 patients. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  Matthias Guckenberger,et al.  Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer. , 2014, International journal of radiation oncology, biology, physics.

[11]  David J Brenner,et al.  The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? , 2014, International journal of radiation oncology, biology, physics.

[12]  Zhongxing Liao,et al.  What Would Be the Most Appropriate α/β Ratio in the Setting of Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer , 2013, BioMed research international.

[13]  Matthias Guckenberger,et al.  Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Ewan Cameron,et al.  On the Estimation of Confidence Intervals for Binomial Population Proportions in Astronomy: The Simplicity and Superiority of the Bayesian Approach , 2010, Publications of the Astronomical Society of Australia.

[15]  R. Griffin,et al.  Radiobiology of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy , 2011 .

[16]  Zhibin Huang,et al.  A Generalized Linear-Quadratic Model for Radiosurgery, Stereotactic Body Radiation Therapy, and High–Dose Rate Brachytherapy , 2010, Science Translational Medicine.

[17]  W. Tomé.  Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy: in regard to Parks et al. (Int J Radiat Oncol Biol Phys 2008;70:847-852). , 2008, International journal of radiation oncology, biology, physics.

[18]  J. Fowler.  Linear quadratics is alive and well: in regard to Park et al. (Int J Radiat Oncol Biol Phys 2008;70:847-852). , 2008, International journal of radiation oncology, biology, physics.

[19]  M. Astrahan,et al.  Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation. , 2008, Medical physics.

[20]  Lech Papiez,et al.  Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[21]  Bradley P Carlin,et al.  Flexible Cure Rate Modeling Under Latent Activation Schemes , 2007, Journal of the American Statistical Association.

[22]  Vladimir A Semenenko,et al.  Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters. , 2006, Medical physics.

[23]  Joseph G. Ibrahim,et al.  A New Bayesian Model For Survival Data With a Surviving Fraction , 1999 .

[24]  R. Valdagni.  Altered Fractionation in Radiotherapy , 1998, Tumori.